D-66403-004 Class II Terminated
FDA drug recall D-66403-004 was initiated by Mylan Pharmaceuticals Inc. on Sep 13, 2013 and is designated Class II. Reason for recall: CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices. The recall status is terminated (terminated Jul 23, 2015). Affected quantity: 521 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 13, 2013
- Initiation Date
- Sep 13, 2013
- Termination Date
- Jul 23, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 521 bottles
Product description
Ciprofloxacin Tablets, USP, 250 mg, 100-count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-7097-01
Reason for recall
CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: 3032075, 3032076
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-66403-004
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026